Quantum BioPharma wins FDA clearance for Lucid-MS Phase 2 trial - QNTM News | RalliesQuantum BioPharma wins FDA clearance for Lucid-MS Phase 2 trial
Q
QNTM• FDA clears Lucid-MS Phase 2 trial
- Quantum BioPharma secured FDA clearance to start a Phase 2 trial of Lucid-MS in multiple sclerosis.
- Lucid-MS targets protection or potential rebuilding of the myelin sheath rather than immune suppression.
- The company framed the program as a first-in-class human test of this mechanism in MS.
MUA
•
